AN2 Therapeutics, Inc. ($ANTX)
Filing Information
| Accession Number | 0001193125-26-253622 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 2, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
265
Total Value
$1,173.95
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Principal Accounting Officer | Common Stock | โ | May 29, 2026 | Sale | 265 | $4.43 | $1,173.95 | 66,583 | Direct | โ | View Details |